learn RU58841
a potent but unapproved and potentially problematic topical anti-androgen
Search
for🛒 Where to find RU58841
Tracking 8 topical products and 5 raw products by companies like Amazon, Anageninc, Chemyo and MV supplements . View all 13 products »Community Join
5 / 13 resultscommunity The story of RU58841 / PSK 3841
RU58841, Minoxidil, and finasteride are discussed as treatments for hair loss. RU58841 is highlighted for its potential effectiveness.
community The story of RU58841/PSK3841
RU58841, an anti-androgenic compound, showed early promise for treating alopecia but faced challenges after its patent in 1997. Despite advancing to Phase II trials, safety concerns and financial struggles led Aventis to abandon its development. Proskelia, which later merged into ProStrakan, couldn't prioritize the drug, leading to its eventual stagnation and failure to reach the market.
community The story of RU58841/ PSK3841
RU58841, a potential hair loss treatment, was not commercialized due to marketability issues and lack of long-term safety data. Concerns about its formulation and delivery methods further complicate its use.
community I spoke to the Guy who did the Ru58841 (PSK-3841) research
The conversation discusses RU58841, a compound for hair loss treatment, which was found to be effective in a 6-month trial but was not pursued due to financial issues or marketability concerns, not safety. Some users are considering crowdfunding to release the research data, while others discuss personal experiences and safety concerns with RU58841.
community Research about RU58841 /Why it was stopped
RU58841 showed promise for treating androgenic alopecia but research was halted due to financial and organizational changes. There were no significant safety concerns reported in human trials.
Research
5 / 1000+ resultsresearch A multi-centre, double-blind, randomised, vehicle-controlled study for a quantitative estimation of hair re-growth in male subjects with androgenetic alopecia treated over 6 month with two ethanolic PSK 3841 solutions (2.5% and 5%)
research A double blind, randomised, vehicle-controlled, safety and tolerance study of topical PSK 3841 solution at 5% administered twice daily over four weeks to healthy Caucasian males with androgenetic alopecia
research Investigational medications in the treatment of alopecia
New treatments for hair loss are being developed using molecular biology.
research Experimental and early investigational drugs for androgenetic alopecia
New hair loss treatments may include topical medications, injections, and improved transplant methods.
research Nouvelles thérapeutiques dans la prise en charge de l’alopécie androgénétique
De nouvelles thérapies promettent de mieux traiter la perte de cheveux due à l'alopécie androgénétique.
Experts
6 / 20 results- 9SMP Specialist
Zach
Incomplete name
State College, PA, United States
- 2SMP Specialist
Suky
Incomplete name
Slough, United Kingdom
- 90
Hair Transplant SurgeonDr. Zaki Kayali
Langley, BC, Canada
- 94
Hair Transplant SurgeonDr. Zack Charkawi, MD, ABHRS
Johns Creek, GA, United States
- 66SMP Specialist
Souky Garcia
Kitchener, ON, Canada
- 5Hair Loss Specialist
Sacha Piedallu
Surat, Gujarat, India
Clinics
6 / 12 results- 38SMPSaç Simülasyon MerkeziSeyhan · TR
- 64
Hair Loss TreatmentsSC Hair RestorationBraddock, PA · US - 56SMPSC SMP CENTERİstanbul · TR
- 78Hair TransplantHair Loss TreatmentsSaç Ekim MerkeziAnkara · TR
- 59Hair TransplantHair Loss TreatmentsSaç Ekim Merkeziİzmir · TR
- 22
Hair Loss TreatmentsSMPSaç Simülasyon ve GölgelendirmeBursa · TR